CAGNONI PABLO J
President, Global Head of R&D
Sale 10b5-1
- Shares
- 2,642
- Price
- $112.71
- Value
- $297,780
SEC EDGAR · Forms 3/4/5Updated through Oct 30, 2026•111 filings
INCY
INCYTE CORP
Net sales of $15M over the last 3 months
2 sellers account for the net balance. There is no cluster of three distinct buyers within 30 days. We found no CEO/CFO purchases over 12 months.
How to read this signal
Only open-market P purchases and S sales count toward the signal. Vesting, options, taxes and gifts remain in the source data but do not trigger alerts. Rule 10b5-1 trades are shown as informational.
3-month balance
−$14,963,612
0 buyers · 2 sellers
12-month purchases
$0.00
0 distinct insiders
12-month sales
$58,259,746
10 distinct insiders
Highlighted alerts
0
54 Rule 10b5-1 trades treated as informational
Buying cluster · 30 days
Fewer than three distinct buyers
CEO/CFO purchases · 12 months
No executive purchases found
Get INCY insider trades by API
The same filtered trades as JSON for your scripts, alerts or AI agent, for 5,500+ US companies — plus sentiment, news, financials and breakout setups. Free · every API · 1,000 requests a month · no card required.
INCY overview: breakout setup, X sentiment and insiders in one page →
Form 4 raw → Raspberry
The value is in what we do not call a signal.
The SEC XML stores every transaction. Raspberry keeps that evidence, reads the footnotes and separates voluntary open-market activity from vesting, option exercises, gifts, tax withholding, stock purchase and dividend reinvestment plans and pre-programmed 10b5-1 trades.
100
Raw transactions
Everything returned by the filing
54
Voluntary view
P/S trades after deterministic checks
79
Administrative noise
Stored, never alerted
75
10b5-1
Shown as informational
SEC ownership XML facts
- Code
- M
- Shares
- 925
- Price
- $64.25
- Footnotes
- 5
This includes an aggregate of 183,200 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested. Beginning January 17, 2025, options become exercisable in 37 installments, with the first 25% vesting on July 15, 2025 and the remainder vesting monthly over three years. The July 14, 2023 options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years. Beginning January 18, 2024, options become exercisable in 37 installments, with the first 25% vesting on July 14, 2024 and the remainder vesting monthly over three years. The July 15, 2024 options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years.
Raspberry interpretation
Informational — no alert
Reason: administrative_code. The trade is reported under a Rule 10b5-1 plan.
Recent transactions
Voluntary purchases and sales; administrative noise stays hidden.
CAGNONI PABLO J
President, Global Head of R&D
Sale 10b5-1
- Shares
- 13,985
- Price
- $120.49
- Value
- $1,685,053
CAGNONI PABLO J
President, Global Head of R&D
Sale 10b5-1
- Shares
- 9,233
- Price
- $120.50
- Value
- $1,112,577
CAGNONI PABLO J
President, Global Head of R&D
Sale 10b5-1
- Shares
- 10,801
- Price
- $125.56
- Value
- $1,356,174
CAGNONI PABLO J
President, Global Head of R&D
Sale 10b5-1
- Shares
- 10,803
- Price
- $120.04
- Value
- $1,296,792
Mayes Patrick A
EVP & Chief Scientific Officer
Sale 10b5-1
- Shares
- 2,207
- Price
- $123.99
- Value
- $273,646
CAGNONI PABLO J
President, Global Head of R&D
Sale 10b5-1
- Shares
- 10,640
- Price
- $122.69
- Value
- $1,305,422
Mayes Patrick A
EVP & Chief Scientific Officer
Sale 10b5-1
- Shares
- 6,055
- Price
- $120.43
- Value
- $729,204
Mayes Patrick A
EVP & Chief Scientific Officer
Sale 10b5-1
- Shares
- 2,293
- Price
- $119.41
- Value
- $273,807
Mayes Patrick A
EVP & Chief Scientific Officer
Sale 10b5-1
- Shares
- 326
- Price
- $121.69
- Value
- $39,671
Mayes Patrick A
EVP & Chief Scientific Officer
Sale 10b5-1
- Shares
- 85
- Price
- $122.19
- Value
- $10,386
Mayes Patrick A
EVP & Chief Scientific Officer
Sale 10b5-1
- Shares
- 1,642
- Price
- $119.38
- Value
- $196,022
Mayes Patrick A
EVP & Chief Scientific Officer
Sale 10b5-1
- Shares
- 1,643
- Price
- $119.51
- Value
- $196,355
Mayes Patrick A
EVP & Chief Scientific Officer
Sale 10b5-1
- Shares
- 2,864
- Price
- $119.40
- Value
- $341,962
Mayes Patrick A
EVP & Chief Scientific Officer
Sale 10b5-1
- Shares
- 4,695
- Price
- $119.39
- Value
- $560,536
Mayes Patrick A
EVP & Chief Scientific Officer
Sale 10b5-1
- Shares
- 6,171
- Price
- $119.43
- Value
- $737,003
Mayes Patrick A
EVP & Chief Scientific Officer
Sale 10b5-1
- Shares
- 2,187
- Price
- $119.47
- Value
- $261,281
Mayes Patrick A
EVP & Chief Scientific Officer
Sale 10b5-1
- Shares
- 5,332
- Price
- $119.42
- Value
- $636,747
Mayes Patrick A
EVP & Chief Scientific Officer
Sale 10b5-1
- Shares
- 14,661
- Price
- $119.46
- Value
- $1,751,403
CAGNONI PABLO J
President, Global Head of R&D
Sale 10b5-1
- Shares
- 15,888
- Price
- $119.70
- Value
- $1,901,794
Issa Mohamed Khairie
EVP, Head of U.S. Commercial
Sale 10b5-1
- Shares
- 1,093
- Price
- $115.01
- Value
- $125,706
Stein Steven H
CMO & Head of Late-Stage Dev.
Sale 10b5-1
- Shares
- 1,877
- Price
- $114.73
- Value
- $215,348
Stein Steven H
CMO & Head of Late-Stage Dev.
Sale 10b5-1
- Shares
- 28,237
- Price
- $113.05
- Value
- $3,192,193
Tray Thomas
Principal Accounting Officer
Sale 10b5-1
- Shares
- 2,639
- Price
- $100.00
- Value
- $263,900
Tray Thomas
Principal Accounting Officer
Sale 10b5-1
- Shares
- 2,051
- Price
- $97.35
- Value
- $199,665
Clancy Paul J
Director
Sale 10b5-1
- Shares
- 15,000
- Price
- $94.93
- Value
- $1,423,950
CAGNONI PABLO J
President, Global Head of R&D
Sale 10b5-1
- Shares
- 18,667
- Price
- $96.50
- Value
- $1,801,366
CAGNONI PABLO J
President, R&D
Sale 10b5-1
- Shares
- 18,667
- Price
- $94.24
- Value
- $1,759,178
CAGNONI PABLO J
President, R&D
Sale 10b5-1
- Shares
- 18,668
- Price
- $100.91
- Value
- $1,883,788
Issa Mohamed Khairie
EVP, Head of US Oncology
Sale 10b5-1
- Shares
- 10,856
- Price
- $109.07
- Value
- $1,184,064
Stein Steven H
EVP & Chief Medical Officer
Sale 10b5-1
- Shares
- 15,634
- Price
- $101.70
- Value
- $1,589,978
Tray Thomas
Principal Accounting Officer
Sale 10b5-1
- Shares
- 2,774
- Price
- $100.00
- Value
- $277,400
Tray Thomas
Principal Accounting Officer
Sale 10b5-1
- Shares
- 600
- Price
- $98.25
- Value
- $58,950
Morrissey Michael James
EVP, Head of Tech. Operations
Sale 10b5-1
- Shares
- 4,323
- Price
- $97.26
- Value
- $420,455
Morrissey Michael James
EVP, Head of Tech. Operations
Sale 10b5-1
- Shares
- 53,175
- Price
- $97.29
- Value
- $5,173,396
Morrissey Michael James
EVP, Head of Tech. Operations
Sale 10b5-1
- Shares
- 833
- Price
- $97.42
- Value
- $81,151
Mayes Patrick A
EVP & Chief Scientific Officer
Sale 10b5-1
- Shares
- 255
- Price
- $94.94
- Value
- $24,210
Mayes Patrick A
EVP & Chief Scientific Officer
Sale 10b5-1
- Shares
- 5,553
- Price
- $95.58
- Value
- $530,756
Stein Steven H
EVP & Chief Medical Officer
Sale 10b5-1
- Shares
- 20,105
- Price
- $102.51
- Value
- $2,060,964
Stein Steven H
EVP & Chief Medical Officer
Sale 10b5-1
- Shares
- 2,559
- Price
- $102.96
- Value
- $263,475
Tray Thomas
Principal Accounting Officer
Sale 10b5-1
- Shares
- 600
- Price
- $103.00
- Value
- $61,800
Tray Thomas
Principal Accounting Officer
Sale 10b5-1
- Shares
- 169
- Price
- $102.00
- Value
- $17,238
Denton Sheila A.
EVP & General Counsel
Sale 10b5-1
- Shares
- 278
- Price
- $104.36
- Value
- $29,012
Hoppenot Herve
Director
Sale 10b5-1
- Shares
- 187,500
- Price
- $105.46
- Value
- $19,773,750
Stein Steven H
EVP & Chief Medical Officer
Sale 10b5-1
- Shares
- 5,233
- Price
- $102.20
- Value
- $534,813
Denton Sheila A.
EVP & General Counsel
Sale 10b5-1
- Shares
- 598
- Price
- $101.36
- Value
- $60,613
Heeson Lee
EVP, Head of Incyte Intl
Sale 10b5-1
- Shares
- 3,074
- Price
- $94.02
- Value
- $289,017
Denton Sheila A.
EVP & General Counsel
Sale 10b5-1
- Shares
- 277
- Price
- $85.13
- Value
- $23,581
Denton Sheila A.
EVP & General Counsel
Sale 10b5-1
- Shares
- 3,501
- Price
- $85.54
- Value
- $299,476
Denton Sheila A.
EVP & General Counsel
Sale 10b5-1
- Shares
- 599
- Price
- $87.65
- Value
- $52,502
Denton Sheila A.
EVP & General Counsel
Sale 10b5-1
- Shares
- 278
- Price
- $83.15
- Value
- $23,116
Denton Sheila A.
EVP & General Counsel
Sale 10b5-1
- Shares
- 598
- Price
- $84.97
- Value
- $50,812
Denton Sheila A.
EVP & General Counsel
Sale 10b5-1
- Shares
- 277
- Price
- $86.81
- Value
- $24,046
Denton Sheila A.
EVP & General Counsel
Sale 10b5-1
- Shares
- 598
- Price
- $75.77
- Value
- $45,310
| Date | Insider | Transaction | Shares | Price | Value | Reading |
|---|---|---|---|---|---|---|
| Oct 15, 2026 | CAGNONI PABLO J President, Global Head of R&D | Sale | 2,642 | $112.71 | $297,780 | |
| Sep 15, 2026 | CAGNONI PABLO J President, Global Head of R&D | Sale | 13,985 | $120.49 | $1,685,053 | |
| Sep 15, 2026 | CAGNONI PABLO J President, Global Head of R&D | Sale | 9,233 | $120.50 | $1,112,577 | |
| Aug 19, 2026 | CAGNONI PABLO J President, Global Head of R&D | Sale | 10,801 | $125.56 | $1,356,174 | |
| Aug 12, 2026 | CAGNONI PABLO J President, Global Head of R&D | Sale | 10,803 | $120.04 | $1,296,792 | |
| Aug 05, 2026 | Mayes Patrick A EVP & Chief Scientific Officer | Sale | 2,207 | $123.99 | $273,646 | |
| Aug 05, 2026 | CAGNONI PABLO J President, Global Head of R&D | Sale | 10,640 | $122.69 | $1,305,422 | |
| Aug 03, 2026 | Mayes Patrick A EVP & Chief Scientific Officer | Sale | 6,055 | $120.43 | $729,204 | |
| Jul 31, 2026 | Mayes Patrick A EVP & Chief Scientific Officer | Sale | 2,293 | $119.41 | $273,807 | |
| Jul 31, 2026 | Mayes Patrick A EVP & Chief Scientific Officer | Sale | 326 | $121.69 | $39,671 | |
| Jul 31, 2026 | Mayes Patrick A EVP & Chief Scientific Officer | Sale | 85 | $122.19 | $10,386 | |
| Jul 31, 2026 | Mayes Patrick A EVP & Chief Scientific Officer | Sale | 1,642 | $119.38 | $196,022 | |
| Jul 31, 2026 | Mayes Patrick A EVP & Chief Scientific Officer | Sale | 1,643 | $119.51 | $196,355 | |
| Jul 31, 2026 | Mayes Patrick A EVP & Chief Scientific Officer | Sale | 2,864 | $119.40 | $341,962 | |
| Jul 31, 2026 | Mayes Patrick A EVP & Chief Scientific Officer | Sale | 4,695 | $119.39 | $560,536 | |
| Jul 31, 2026 | Mayes Patrick A EVP & Chief Scientific Officer | Sale | 6,171 | $119.43 | $737,003 | |
| Jul 31, 2026 | Mayes Patrick A EVP & Chief Scientific Officer | Sale | 2,187 | $119.47 | $261,281 | |
| Jul 31, 2026 | Mayes Patrick A EVP & Chief Scientific Officer | Sale | 5,332 | $119.42 | $636,747 | |
| Jul 31, 2026 | Mayes Patrick A EVP & Chief Scientific Officer | Sale | 14,661 | $119.46 | $1,751,403 | |
| Jul 31, 2026 | CAGNONI PABLO J President, Global Head of R&D | Sale | 15,888 | $119.70 | $1,901,794 | |
| Jul 16, 2026 | Issa Mohamed Khairie EVP, Head of U.S. Commercial | Sale | 1,093 | $115.01 | $125,706 | |
| Jul 16, 2026 | Stein Steven H CMO & Head of Late-Stage Dev. | Sale | 1,877 | $114.73 | $215,348 | |
| Jul 15, 2026 | Stein Steven H CMO & Head of Late-Stage Dev. | Sale | 28,237 | $113.05 | $3,192,193 | |
| Jun 04, 2026 | Tray Thomas Principal Accounting Officer | Sale | 2,639 | $100.00 | $263,900 | |
| May 26, 2026 | Tray Thomas Principal Accounting Officer | Sale | 2,051 | $97.35 | $199,665 | |
| May 19, 2026 | Clancy Paul J Director | Sale | 15,000 | $94.93 | $1,423,950 | |
| Apr 17, 2026 | CAGNONI PABLO J President, Global Head of R&D | Sale | 18,667 | $96.50 | $1,801,366 | |
| Mar 17, 2026 | CAGNONI PABLO J President, R&D | Sale | 18,667 | $94.24 | $1,759,178 | |
| Feb 19, 2026 | CAGNONI PABLO J President, R&D | Sale | 18,668 | $100.91 | $1,883,788 | |
| Jan 07, 2026 | Issa Mohamed Khairie EVP, Head of US Oncology | Sale | 10,856 | $109.07 | $1,184,064 | |
| Jan 05, 2026 | Stein Steven H EVP & Chief Medical Officer | Sale | 15,634 | $101.70 | $1,589,978 | |
| Dec 19, 2025 | Tray Thomas Principal Accounting Officer | Sale | 2,774 | $100.00 | $277,400 | |
| Dec 18, 2025 | Tray Thomas Principal Accounting Officer | Sale | 600 | $98.25 | $58,950 | |
| Dec 17, 2025 | Morrissey Michael James EVP, Head of Tech. Operations | Sale | 4,323 | $97.26 | $420,455 | |
| Dec 16, 2025 | Morrissey Michael James EVP, Head of Tech. Operations | Sale | 53,175 | $97.29 | $5,173,396 | |
| Dec 16, 2025 | Morrissey Michael James EVP, Head of Tech. Operations | Sale | 833 | $97.42 | $81,151 | |
| Dec 11, 2025 | Mayes Patrick A EVP & Chief Scientific Officer | Sale | 255 | $94.94 | $24,210 | |
| Dec 10, 2025 | Mayes Patrick A EVP & Chief Scientific Officer | Sale | 5,553 | $95.58 | $530,756 | |
| Dec 02, 2025 | Stein Steven H EVP & Chief Medical Officer | Sale | 20,105 | $102.51 | $2,060,964 | |
| Dec 01, 2025 | Stein Steven H EVP & Chief Medical Officer | Sale | 2,559 | $102.96 | $263,475 | |
| Nov 24, 2025 | Tray Thomas Principal Accounting Officer | Sale | 600 | $103.00 | $61,800 | |
| Nov 21, 2025 | Tray Thomas Principal Accounting Officer | Sale | 169 | $102.00 | $17,238 | |
| Nov 17, 2025 | Denton Sheila A. EVP & General Counsel | Sale | 278 | $104.36 | $29,012 | |
| Nov 10, 2025 | Hoppenot Herve Director | Sale | 187,500 | $105.46 | $19,773,750 | |
| Nov 05, 2025 | Stein Steven H EVP & Chief Medical Officer | Sale | 5,233 | $102.20 | $534,813 | |
| Nov 04, 2025 | Denton Sheila A. EVP & General Counsel | Sale | 598 | $101.36 | $60,613 | |
| Nov 03, 2025 | Heeson Lee EVP, Head of Incyte Intl | Sale | 3,074 | $94.02 | $289,017 | |
| Oct 15, 2025 | Denton Sheila A. EVP & General Counsel | Sale | 277 | $85.13 | $23,581 | |
| Oct 03, 2025 | Denton Sheila A. EVP & General Counsel | Sale | 3,501 | $85.54 | $299,476 | |
| Oct 02, 2025 | Denton Sheila A. EVP & General Counsel | Sale | 599 | $87.65 | $52,502 | |
| Sep 16, 2025 | Denton Sheila A. EVP & General Counsel | Sale | 278 | $83.15 | $23,116 | |
| Sep 02, 2025 | Denton Sheila A. EVP & General Counsel | Sale | 598 | $84.97 | $50,812 | |
| Aug 15, 2025 | Denton Sheila A. EVP & General Counsel | Sale | 277 | $86.81 | $24,046 | |
| Aug 04, 2025 | Denton Sheila A. EVP & General Counsel | Sale | 598 | $75.77 | $45,310 |